Minnie Abromowitch

Children's Hospital

Boston, Massachusetts - 02115 (617-355-6058)

CLINICAL TRIALS 1
CONDITIONS5
INTERVENTIONS7
SINCE2007

Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Previously Untreated High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor

March 2007 - December 2012

Nervous System Neoplasms

Central Nervous System Neoplasms

Neuroectodermal Tumors, Primitive

Medulloblastoma

Neuroectodermal Tumors

Filgrastim

Carboplatin

Cisplatin

Cyclophosphamide

Radiation Therapy

Vincristine Sulfate

Isotretinoin

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Minnie Abromowitch

Children's Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP